Company

GondolaBio

Biotechnology Research Palo Alto, California, United States 46 employees

Employees: 46
Contacts: 3
Emails: 3
Phones: 2

gondolabio.com LinkedIn Crunchbase

GondolaBio Overview

Headquarters: Palo Alto, California, United States
Website: gondolabio.com
Industry: Biotechnology Research
Employees: 46
Funding: 300.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

with academic innovation.

About GondolaBio

GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, including neurology, pulmonology, cardiology, nephrology, and endocrinology. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation.

GondolaBio Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 2; 50.0% coverage

GondolaBio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Elizabeth Holland	Fractional/interim Human Resources		View
Radhika Mathur, Ph.d.	Asset Acquisitions at Gondolabio	San Francisco, California, United States	Email
Cybele Gouverneur	Global Patient Advocacy Lead	Houston, Texas, United States	Email Phone
Jill Sherman	Talent Acquisition	United States	Email Phone